electroCore to Participate in Upcoming Investor Conferences

ROCKAWAY, N.J., Aug. 03, 2026 — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences: Needham 11th Annual Virtual MedTech and Diagnostics Conference , taking place virtually on Tuesday, August 11, 2026. Management will host one-on-one meetings virtually. Canaccord Genuity 46th Annual Growth Conference , taking place in Boston, Massachusetts, on Tuesday, August 11, and Wednesday, August 12, 2026, at the InterContinental Boston. Management will present on Tuesday, August 11, at 4:30 p.m. ET and will host one-on-one meetings on Wednesday, August 12. Investors who wish to request a meeting should contact their sales representative at the sponsoring firms or reach out to electroCore Investor Relations at [email protected] . About electroCore, Inc. electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance. For more information, visit www.electrocore.com . Contact: ECOR Investor Relations (973) 302-9253 [email protected]